NOVEL PEPTIDE HAVING 5 LINKED CTL EPITOPES

摘要

This invention provides a cancer antigen peptide that can be administered to a wide range of cancer patients in the form of a peptide vaccine for cancer without the need for HLA typing and regardless of the HLA types of patients. Such peptide having 5 linked CTL epitopes is obtained by linking 5 CTL epitope peptides selected from among CTL epitope peptides derived from tumor antigen molecules that are reported to have the capacity for CTL induction via linkers.